Meet Interventional Cardiologist, Dr. Megan A. Sattler, and learn about her areas of focus, path to medicine, what brought her to Sentara and how the field of Cardiology is evolving.
I'm Megan Sattler and I'm an interventional cardiologist for Sentara cardiology specialists. As an interventional cardiologist. My primary area of focus is definitely standard PC I and complex PC I outside of that, as a general cardiologist, I also have an interest in women's health preventative cardiology and also patients with hypertrophic cardiomyopathy. Like most health care providers, I definitely was drawn to medicine from my interest in science, lifelong learning and a desire to help other people. However, what drew me to cardiology was more personal as I do have my own personal family, history of cardiovascular disease. The most important thing for me in patient care is taking the time to really educate my patients about their disease process. And I really think it's just as important for them to understand what is going on as it is for me to understand and taking that extra time to teach them and to let them know what things to be aware of. I think just helps us both in the long run to provide the best care for them. My medical training took me around the country from New York where I was born and raised to California and then through the Carolinas, but my family now is centered more in Northern Virginia. And that desire to be closer to my family is what brought me to Sentara on top of the fact that of course, it's an excellent health care system that provides high quality care to its patients. What I love about cardiology is the fact that it's always expanding and there's always something new that's on the horizon. And for patients, I think what's very exciting right now is definitely some of the Perky Tania's treatments for valvular interventions. And also Watchman devices for a fib from a interventional cardiology standpoint drug coated balloons are also on the way and I have a lot of personal interest in that for patients who have instant re stenosis in particular. And so then of course, on a non procedural level, there are lots of new medications that are coming out for treatment of heart disease, including PCS, canine inhibitors for high cholesterol and also different specific treatments for different types of cardiomyopathy, including two feminists for Amyloid.
BROADCASTMED